Over 76,000 People Will Develop Melanoma in 20161.
Melanoma is Rising
In 2016, it’s estimated that melanoma will kill over 10,000 patients in the U.S. With 21.8 new cases and 2.7 deaths per 100,000 annually, melanoma is the 6th most common cancer. Rising at an alarming rate, incidence of melanoma has risen on an average of 1.4% each year over the last 10 years. 84% of melanoma are diagnosed at the local stage, while 4% are diagnosed at the distant stage, which is metastatic melanoma.1
Traditional Test Methods are Insufficient
Key mutations in BRAF, NRAS, and c-KIT often go undetected by traditional PCR-based tests. Missing these indicators leaves oncologists with incomplete information, leading to treatment plans that are less targeted and personalized.